Manufacturing alerts and issues at Teva, Pfizer, and more
Pfizer to settle Xeljanz suit with Teva
Pfizer wins Viagra patent battle against Teva
Pfizer, GSK and Teva lead 2022's round of January drug price hikes: GoodRx | FiercePharma
Generic Viagra Half the Price Teva Pfizer
Teva wins battle with Pfizer over Viagra patent | Managing Intellectual Property
Teva Pharmaceuticals - Wikipedia
Pfizer in $2.15 Billion Settlement From Teva and Sun for Patent Infringement
Mylan-Pfizer off-patent merger boosts Teva - Globes
Bad news for Momenta and Pfizer is a blessing for Teva
Teva, Mylan: Desperate Times Call For Desperate Measures (NYSE:TEVA) | Seeking Alpha
Pfizer's legendary Viagra finally set to face cheaper competition in U.S. | FiercePharma
Generic Drug Maker Teva Settles With Pfizer Over Patent Dispute, In Pharma Court Battle
Pfizer's Kindler KO'd by Teva's Yanai
Manufacturing Delay Of Generic Drug From Pfizer Inc. (PFE) A Relief For Teva Pharmaceutical Industries Ltd (ADR) (TEVA) - Insider Monkey
Pfizer, Teva reach deal to allow generic Viagra-World News , Firstpost
Pfizer scrambles to fill void after Teva stops making chemo drug often given to children | FiercePharma
Pfizer, Takeda Reach $2.15 Billion Settlement With Teva, Sun Pharma - WSJ
Teva says it's in talks with COVID vaccine makers to help produce shots | The Times of Israel
Global Competition Review - Pfizer and Teva face new drug delay action
Better Big Pharma Dividend Stock: Pfizer Or Teva? | Seeking Alpha
Teva Shares Up on Mylan-Pfizer Merger - Hamodia.com
Pfizer, Teva and Actavis Vie to Buy Ratiopharm - The New York Times
